LivaNova PLC Amortization of Debt Issuance Costs
LivaNova PLC (LIVN) reported Amortization of Debt Issuance Costs of $4.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-05
- LivaNova PLC amortization of debt issuance costs for the quarter ending 2026-06-30 was $4.90M, a 14.04% decline year-over-year.
- LivaNova PLC amortization of debt issuance costs for the quarter ending 2026-03-31 was $4.77M, a 15.98% decline year-over-year.
- LivaNova PLC amortization of debt issuance costs for the quarter ending 2025-12-31 was $5.80M, a 1.81% decline year-over-year.
- LivaNova PLC amortization of debt issuance costs for the quarter ending 2025-09-30 was $5.90M, a 7.27% increase year-over-year.
- LivaNova PLC amortization of debt issuance costs for fiscal 2025 was $23.06M, a 6.76% increase from fiscal 2024.
- LivaNova PLC amortization of debt issuance costs for fiscal 2024 was $21.60M, a 13.36% increase from fiscal 2023.
- LivaNova PLC amortization of debt issuance costs for fiscal 2023 was $19.05M, a 10.69% decline from fiscal 2022.
- LivaNova PLC amortization of debt issuance costs for fiscal 2022 was $21.33M, a 28.08% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.90M 10-Q · filed 2026-08-05 | $9.71M 10-Q · filed 2026-08-05 | $15.47M derived: sum of 3 quarters · filed 2026-08-05 | $21.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $4.77M 10-Q · filed 2026-05-06 | $10.57M derived: sum of 2 quarters · filed 2026-05-06 | $16.47M derived: sum of 3 quarters · filed 2026-05-06 | $22.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.70M derived: sum of 2 quarters · filed 2026-02-25 | $17.40M derived: sum of 3 quarters · filed 2026-08-05 | $23.06M 10-K · filed 2026-02-25 |
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-05 | $11.60M derived: sum of 2 quarters · filed 2026-08-05 | $17.26M 10-Q · filed 2025-11-05 | $23.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.70M 10-Q · filed 2026-08-05 | $11.40M 10-Q · filed 2026-08-05 | $17.28M derived: sum of 3 quarters · filed 2026-08-05 | $22.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.68M 10-Q · filed 2026-05-06 | $11.58M derived: sum of 2 quarters · filed 2026-05-06 | $17.08M derived: sum of 3 quarters · filed 2026-05-06 | $22.38M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.41M derived: sum of 2 quarters · filed 2026-02-25 | $16.71M derived: sum of 3 quarters · filed 2026-02-25 | $21.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | $5.50M 10-Q · filed 2025-11-05 | $10.80M derived: sum of 2 quarters · filed 2025-11-05 | $15.69M 10-Q · filed 2025-11-05 | $20.51M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $5.30M 10-Q · filed 2025-08-06 | $10.20M 10-Q · filed 2025-08-06 | $15.01M derived: sum of 3 quarters · filed 2026-02-25 | $19.71M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-07 | $9.71M derived: sum of 2 quarters · filed 2026-02-25 | $14.41M derived: sum of 3 quarters · filed 2026-02-25 | $18.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.51M derived: sum of 2 quarters · filed 2026-02-25 | $14.02M derived: sum of 3 quarters · filed 2026-02-25 | $19.05M 10-K · filed 2026-02-25 |
| 2023-09-30 | $4.70M 10-Q · filed 2024-10-31 | $9.22M derived: sum of 2 quarters · filed 2024-10-31 | $14.25M 10-Q · filed 2024-10-31 | $19.18M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $9.54M 10-Q · filed 2024-08-01 | $14.47M derived: sum of 3 quarters · filed 2025-02-25 | $19.15M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $5.02M 10-Q · filed 2024-05-03 | $9.96M derived: sum of 2 quarters · filed 2025-02-25 | $14.63M derived: sum of 3 quarters · filed 2025-02-25 | $21.94M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.61M derived: sum of 2 quarters · filed 2025-02-25 | $16.92M derived: sum of 3 quarters · filed 2025-02-25 | $21.33M 10-K · filed 2025-02-25 |
| 2022-09-30 | $4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.98M derived: sum of 2 quarters · filed 2023-11-01 | $16.39M 10-Q · filed 2023-11-01 | $19.96M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $7.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $11.72M 10-Q · filed 2023-07-26 | $15.29M derived: sum of 3 quarters · filed 2024-02-29 | $19.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.41M 10-Q · filed 2023-05-03 | $7.98M derived: sum of 2 quarters · filed 2024-02-29 | $12.08M derived: sum of 3 quarters · filed 2024-02-29 | $16.66M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.67M derived: sum of 2 quarters · filed 2024-02-29 | $12.25M derived: sum of 3 quarters · filed 2024-02-29 | $16.66M 10-K · filed 2024-02-29 |
| 2021-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $8.68M derived: sum of 2 quarters · filed 2022-11-02 | $13.09M 10-Q · filed 2022-11-02 | $17.33M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $8.99M 10-Q · filed 2022-08-03 | $13.23M derived: sum of 3 quarters · filed 2023-02-27 | $17.48M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $4.41M 10-Q · filed 2022-05-04 | $8.65M derived: sum of 2 quarters · filed 2023-02-27 | $12.90M derived: sum of 3 quarters · filed 2023-02-27 | $13.58M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $8.49M derived: sum of 2 quarters · filed 2023-02-27 | $9.17M derived: sum of 3 quarters · filed 2023-02-27 | $9.71M 10-K · filed 2023-02-27 |
| 2020-09-30 | $4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $4.92M derived: sum of 2 quarters · filed 2021-11-03 | $5.47M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.22M 10-Q · filed 2021-07-28 | ||
| 2020-03-31 | $543.00K 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | $2.20M 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $222.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |